NASA’s 1st humanoid robot in space will aid with medical tasks

Astronauts sometimes need medical care, too, and NASA has developed a robot to administer such care.

Advertisement

The Robonaut 2, a second generation humanoid robot developed by the space agency, lives on the International Space Station. It is the first humanoid robot in space.

In addition to assisting astronauts on missions and, for example, providing an extra pair of ambidextrous hands, R2 is undergoing testing for its telemedicine capabilities. Currently, the Houston Methodist Research Institute and NASA are testing R2’s abilities for conducting medical procedures through electronic communication or remotely operating R2 to conduct ultrasounds or use syringes.

R2 is the next generation iteration of Robonaut, called R1, which was built as an exploratory prototype to determine the robot’s capabilities in space. R2 is faster and more dexterous, according to NASA.

The robot was named the NASA Government Invention of the Year in 2014, recognizing the robot as achieving one of NASA’s missions to transfer advanced technology to U.S. industry.

More articles on health IT:

25 things to know about health IT interoperability
8 recent vendor contracts, go-lives
50 things to know about Epic and Judy Faulkner

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.